ライフサイエンスコーパス: endothelial progenitor cell

1 ycerol sebacate)) with a single cell source (endothelial progenitor cells).

2 linase in microparticle-induced apoptosis of endothelial progenitor cells.

3 enhanced recruitment of bone marrow-derived endothelial progenitor cells.

4 lial marker CD31, suggesting the presence of endothelial progenitor cells.

5 in these hematopoietic tissues gives rise to endothelial progenitor cells.

6 of edema, and depletion of regulatory T and endothelial progenitor cells.

7 epletion restores the functional capacity of endothelial progenitor cells.

8 It has also been used to identify endothelial progenitor cells.

9 associated with mobilization of circulating endothelial progenitor cells.

10 t abnormalities in phenotype and function of endothelial progenitor cells.

11 f promoting endothelial regeneration through endothelial progenitor cells.

12 th tumor endothelial and bone marrow-derived endothelial progenitor cells.

13 cripts in ischemic tissue and in circulating endothelial progenitor cells.

14 air of injured microvasculature by providing endothelial progenitor cells.

15 enhanced recruitment of bone marrow-derived endothelial progenitor cells.

16 iginate from hematopoietic stem cell-derived endothelial progenitor cells.

17 ng a mixture of cardiac progenitor cells and endothelial progenitor cells.

18 ability to differentiate into erythroid and endothelial progenitor cells.

19 Endometriotic lesions increased circulating endothelial progenitor cells 13 days after engraftment,

20 eated with intramuscular bone marrow-derived endothelial progenitor cells [2.0 x 10 cells]), group 4

21 e of a role for bone marrow-derived putative endothelial progenitor cells after iatrogenic vascular i

22 to a profound decrease in the recruitment of endothelial progenitor cells and a reduction of peribron

23 ntly increased numbers of VEGFR2(+)/AC133(+) endothelial progenitor cells and CD34(+)/VEGFR1(+) hemat

24 Combined treatment with bone marrow-derived endothelial progenitor cells and extracorporeal shock wa

25 Next, resident endothelial progenitor cells and hematopoietic stem cell

26 Exogenous uric acid rapidly mobilizes endothelial progenitor cells and hematopoietic stem cell

27 l plaque volume but does stabilize levels of endothelial progenitor cells and improve microvascular f

28 r analog [ESA]) induces continuous homing of endothelial progenitor cells and improves left ventricul

29 nrecognized cell type, function as lymphatic endothelial progenitor cells and participate in postnata

30 actor-1 (SDF-1) is a chemokine that attracts endothelial progenitor cells and promotes angiogenesis.

31 IL-1beta and IL-18, and coadministration of endothelial progenitor cells and stromal cell-derived fa

32 stigate the identity of BM-derived lymphatic endothelial progenitor cells and their role in lymphatic

33 icity of cardiac fibroblasts and circulating endothelial progenitor cells, and consider what role the

34 ty over the precise identity and function of endothelial progenitor cells, and harnessing their thera

35 es consistent with cardiac progenitor cells, endothelial progenitor cells, and mesenchymal stem cells

36 Signaling between endothelial cells, endothelial progenitor cells, and stromal cells is cruci

37 ently, it remains controversial how vascular endothelial progenitor cells (angioblasts) establish the

38 Endothelial progenitor cells are a circulating, bone mar

39 s process is recapitulated in the adult when endothelial progenitor cells are generated in the bone m

40 d cardiovascular progenitor cells, including endothelial progenitor cells, are capable of replacing d

41 The CACs, also termed endothelial progenitor cells, are critical for vascular

42 both bone marrow-derived myelomonocytic and endothelial progenitor cells as well as endothelial cell

43 or cells, rhG-CSF can mobilize dendritic and endothelial progenitor cells as well.

44 Endothelial progenitor cells, as well as HSC/HPCs, were

45 We discovered that bone marrow-derived endothelial progenitor cells (BM-EPC), having the phenot

46 ating TNF-induced RBR in bone marrow-derived endothelial progenitor cells (BM-EPCs).

47 very high degree of deletion in hemopoietic/endothelial progenitor cells but without deletion among

48 rentiated them to both endothelial cells and endothelial progenitor cells by using the embryoid body

49 as well as numbers of inflammatory cells and endothelial progenitor cells (c-kit+/CD31+ cells) in bot

50 Endothelial progenitor cells can restore vessel wall fun

51 forming cells (ECFCs) are a subpopulation of endothelial progenitor cells capable of vasculogenesis i

52 n in primary tumors, including expression of endothelial progenitor cell (CD133 and CD34) and endothe

53 owever, the source of these culture-expanded endothelial progenitor cells (CE-EPCs) remains controver

54 n of ADAM17, modulates postnatal circulating endothelial progenitor cell (CEPC) numbers via effects o

55 Circulating endothelial progenitor cells (cEPCs) are known to contri

56 tem that sustains the release of a bioactive endothelial progenitor cell chemokine during a 4-week pe

57 eeks in vitro, remained active, and enhanced endothelial progenitor cell chemotaxis.

58 t peripheral blood (PB) cytokines predict BM endothelial progenitor cell colony outgrowth and cardiac

59 ary artery disease (CAD) have low numbers of endothelial progenitor cells compared with healthy subje

60 Endothelial progenitor cells contribute to vascular repa

61 lial cells, decreased numbers of circulating endothelial progenitor cells, decreased capillary densit

62 Endothelial/endothelial progenitor cells derived from iPS cells expr

63 In animal models, bone marrow-derived endothelial progenitor cells differentiate into mature e

64 ogenitor cell mobilization from bone marrow, endothelial progenitor cell differentiation, and ultimat

65 ndothelial nitric oxide synthase-transfected endothelial progenitor cells, divided into 3 doses on co

66 etwork mediating developmental plasticity of endothelial progenitor cells during embryonic developmen

67 us mechanism of Hh signaling in angioblasts (endothelial progenitor cells) during arterial-venous spe

68 more, conditioned medium (CM) from embryonic endothelial progenitor cells (eEPCs) rescued the follicu

69 of endothelial cell and bone marrow-derived endothelial progenitor cell (EPC) activity.

70 w PA diabetic (d-PA) concentrations affected endothelial progenitor cell (EPC) and bone marrow-derive

71 Endothelial progenitor cell (EPC) counts are proposed su

72 regard to endothelial vasodilatory function, endothelial progenitor cell (EPC) function, in vivo neoa

73 y increased vascular senescence and impaired endothelial progenitor cell (EPC) function.

74 Reendothelialization involves endothelial progenitor cell (EPC) homing, proliferation,

75 ine human microvascular EC (HMVEC) and human endothelial progenitor cell (EPC) recruitment into engra

76 wound closure rates, neovascularization, and endothelial progenitor cell (EPC) recruitment.

77 gical effects after bone marrow (BM)-derived endothelial progenitor cell (EPC) transplantation into i

78 cumented the role of SIRT1 in reduced EC and endothelial progenitor cell (EPC) viability.

79 h-mobility-group-box-1 (HMGB1) that promotes endothelial progenitor cell (EPC)-mediated neurovascular

80 impaired Lin(-)cKit(+)Sca1(+) (LKS) cell and endothelial progenitor cell (EPC; CD34(+)Flk1(+)) mobili

81 ndothelial cells, thus tethering circulating endothelial progenitor cells (EPC) and facilitating homi

82 Endothelial progenitor cells (EPC) are able to migrate t

83 Bone marrow-derived endothelial progenitor cells (EPC) contribute to the ang

84 s (GSKi) can improve therapeutic efficacy of endothelial progenitor cells (EPC) from patients with DM

85 cal animal models, early clinical studies of endothelial progenitor cells (EPC) have begun.

86 derived from the intended recipient--either endothelial progenitor cells (EPC) or endothelial cell (

87 (SDF-1alpha, a homing signal for recruiting endothelial progenitor cells (EPC) to areas of neovascul

88 Homing of endothelial progenitor cells (EPC) to the ischemic tissu

89 Endothelial progenitor cells (EPC) were successfully cul

90 d cancer progression for bone marrow-derived endothelial progenitor cells (EPC).

91 ed to the recruitment of bone marrow-derived endothelial progenitor cells (EPC).

92 angiomotin as a sCD146-associated protein in endothelial progenitor cells (EPC).

93 otransplantation of peripheral blood-derived endothelial progenitor cells (EPCs) and bone marrow-deri

94 to impairments in vascular repair induced by endothelial progenitor cells (EPCs) and circulating angi

95 study was to determine whether the number of endothelial progenitor cells (EPCs) and circulating angi

96 s were supported by in vitro observations on endothelial progenitor cells (EPCs) and endothelial cell

97 l (E2) modulates the kinetics of circulating endothelial progenitor cells (EPCs) and favorably affect

98 and adhesion capacities of cultured ECs and endothelial progenitor cells (EPCs) and inhibits angioge

99 ll apoptosis and vascular repair mediated by endothelial progenitor cells (EPCs) and myeloid circulat

100 Endothelial progenitor cells (EPCs) and myelomonocytic c

101 The number of circulating endothelial progenitor cells (EPCs) and plasma levels of

102 ed the effect of donor-released CO and NO in endothelial progenitor cells (EPCs) and platelets from n

103 Endothelial progenitor cells (EPCs) are a heterogeneous

104 l cells, and form new vessels, blood-derived endothelial progenitor cells (EPCs) are attractive sourc

105 rculating progenitor cells (CPCs), including endothelial progenitor cells (EPCs) are biologically rel

106 Endothelial progenitor cells (EPCs) are decreased in num

107 Endothelial progenitor cells (EPCs) are essential in vas

108 Marrow-derived endothelial progenitor cells (EPCs) are important in the

109 Mobilization and functions of endothelial progenitor cells (EPCs) are increased in pat

110 Endothelial progenitor cells (EPCs) are known to promote

111 nt study was to determine whether markers of endothelial progenitor cells (EPCs) are present in choro

112 Endothelial progenitor cells (EPCs) are present in the s

113 Circulating endothelial progenitor cells (EPCs) are thought to contr

114 Diverse subsets of endothelial progenitor cells (EPCs) are used for the tre

115 stasis, we identify bone marrow (BM)-derived endothelial progenitor cells (EPCs) as critical regulato

116 ct MVs shed from endothelial cells (ECs) and endothelial progenitor cells (EPCs) by combining microbe

117 ic platform capable of capturing circulating endothelial progenitor cells (EPCs) by understanding sur

118 by extracellular matrix scaffold seeded with endothelial progenitor cells (EPCs) can overcome these l

119 Endothelial progenitor cells (EPCs) can participate with

120 Valvular endothelial cells and circulating endothelial progenitor cells (EPCs) can undergo apparent

121 ata have shown that bone marrow (BM)-derived endothelial progenitor cells (EPCs) contribute to endoth

122 Endothelial progenitor cells (EPCs) contribute to postna

123 Endothelial progenitor cells (EPCs) contribute to vascul

124 etic protein 2 (BMP2) gene-modified MSCs and endothelial progenitor cells (EPCs) could significantly

125 D133(+) and CD34(+) CPCs as well as cultured endothelial progenitor cells (EPCs) derived from blood m

126 In the present study we hypothesized that endothelial progenitor cells (EPCs) enhance production o

127 Endothelial progenitor cells (EPCs) enter the systemic c

128 therosclerosis have increases in circulating endothelial progenitor cells (EPCs) expressing an osteog

129 siderable interest in exploiting circulating endothelial progenitor cells (EPCs) for therapeutic orga

130 We have previously shown that human endothelial progenitor cells (EPCs) form functioning ves

131 xia enhances the mobilization of circulating endothelial progenitor cells (EPCs) from the bone marrow

132 infarction by augmenting the recruitment of endothelial progenitor cells (EPCs) from the bone marrow

133 n in the control of regenerative function of endothelial progenitor cells (EPCs) has not been studied

134 Reduced levels of endothelial progenitor cells (EPCs) have been associated

135 Endothelial progenitor cells (EPCs) have been associated

136 Although different substances that mobilize endothelial progenitor cells (EPCs) have been proposed,

137 Endothelial progenitor cells (EPCs) have been shown to a

138 Bone marrow-derived endothelial progenitor cells (EPCs) have the ability to

139 We hypothesize that blood-derived endothelial progenitor cells (EPCs) have the required pr

140 Little is known about the role of endothelial progenitor cells (EPCs) in atherosclerosis.

141 We aimed to determine the role of endothelial progenitor cells (EPCs) in cholinergic angio

142 Endothelial progenitor cells (EPCs) in ESA gradient, ass

143 The discovery of endothelial progenitor cells (EPCs) in human peripheral

144 ggest a critical role of bone marrow-derived endothelial progenitor cells (EPCs) in neovascularizatio

145 The function of bone marrow-derived endothelial progenitor cells (EPCs) in repair of ischemi

146 The initial discovery of endothelial progenitor cells (EPCs) in tandem with emerg

147 Diabetic individuals have fewer endothelial progenitor cells (EPCs) in their circulation

148 Migration of endothelial progenitor cells (EPCs) into areas of vascul

149 -1); CAFs promote angiogenesis by recruiting endothelial progenitor cells (EPCs) into carcinomas, an

150 The incorporation of endothelial progenitor cells (EPCs) into microvessels co

151 The incorporation of endothelial progenitor cells (EPCs) into newly developin

152 e limited vessel-forming capacity of infused endothelial progenitor cells (EPCs) into patients with c

153 Intracoronary delivery of endothelial progenitor cells (EPCs) is an emerging conce

154 Cell therapy with highly proliferative endothelial progenitor cells (EPCs) is an emerging thera

155 Vascular repair by marrow-derived endothelial progenitor cells (EPCs) is impaired during d

156 d on the phenotypic/functional properties of endothelial progenitor cells (EPCs) is not known.

157 Endothelial progenitor cells (EPCs) may be relevant cont

158 n stimulated by the concept that circulating endothelial progenitor cells (EPCs) may play a role in n

159 Endothelial progenitor cells (EPCs) normally augment ang

160 (SHS) exposure on the number and function of endothelial progenitor cells (EPCs) over 24 h.

161 Because endothelial progenitor cells (EPCs) participate in this

162 In adults, circulating endothelial progenitor cells (EPCs) participate in vascu

163 Endothelial progenitor cells (EPCs) play a critical role

164 Endothelial progenitor cells (EPCs) play an important ro

165 The exact role that bone marrow (BM)-derived endothelial progenitor cells (EPCs) play in tumor neovas

166 Endothelial progenitor cells (EPCs) promote neovasculari

167 and circulating progenitor cells (CPCs) and endothelial progenitor cells (EPCs) PTH, and genetic par

168 Late outgrowth endothelial progenitor cells (EPCs) represent a promisin

169 only isolated from peripheral or cord blood, endothelial progenitor cells (EPCs) returned perfusion t

170 n (TBI) and then infused with C57Bl6-derived endothelial progenitor cells (EPCs) to augment endogenou

171 that estradiol can modulate the kinetics of endothelial progenitor cells (EPCs) via endothelial nitr

172 Endothelial progenitor cells (EPCs) was assayed by flow

173 Endothelial progenitor cells (EPCs) were cultured on the

174 carotid arteries and circulating numbers of endothelial progenitor cells (EPCs) were examined after

175 Circulating endothelial progenitor cells (EPCs) were quantified at b

176 e number of bone marrow and peripheral blood endothelial progenitor cells (EPCs), a marker of vascula

177 mas are composed of endothelial cells (ECs), endothelial progenitor cells (EPCs), as well as perivasc

178 ase, by causing a reduction in the number of endothelial progenitor cells (EPCs), bone marrow-derived

179 Flow cytometry was applied to quantify endothelial progenitor cells (EPCs), circulating endothe

180 Endothelial progenitor cells (EPCs), critical for mediat

181 Endothelial progenitor cells (EPCs), defined as CD34(+)V

182 We hypothesized that adriamycin affects endothelial progenitor cells (EPCs), leading to impaired

183 at PAH patients are deficient in circulating endothelial progenitor cells (EPCs), potentially contrib

184 nclude endothelial microparticles (EMPs) and endothelial progenitor cells (EPCs), respectively.

185 Since the discovery of endothelial progenitor cells (EPCs), there have been con

186 the mobilization of bone marrow (BM)-derived endothelial progenitor cells (EPCs), thereby enhancing n

187 is associated with a deficit of circulating endothelial progenitor cells (EPCs), which has been attr

188 have profound effects on the endothelium and endothelial progenitor cells (EPCs), which originate fro

189 etic cells that provide vascular support and endothelial progenitor cells (EPCs), which under certain

190 eovascularization is controversial, but BMD--endothelial progenitor cells (EPCs)--are strongly implic

191 cells (CECs), angiogenic growth factors, and endothelial progenitor cells (EPCs).

192 e-induced recruitment of bone marrow-derived endothelial progenitor cells (EPCs).

193 Bone marrow (BM) is the major reservoir for endothelial progenitor cells (EPCs).

194 novo recruitment of bone marrow (BM)-derived endothelial progenitor cells (EPCs).

195 ther mobilization or survival of circulating endothelial progenitor cells (EPCs).

196 repair by regenerative endothelial cells and endothelial progenitor cells (EPCs).

197 ), and group 5 (combined bone marrow-derived endothelial progenitor cell-extracorporeal shock wave) a

198 During embryogenesis, lymphatic endothelial progenitor cells first arise from a subset o

199 we demonstrate the isolation of CD34+/Flk1+ endothelial progenitor cells from blood enabled by the d

200 exact phenotype of the cells with lymphatic endothelial progenitor cell function has yet to be ident

201 ent vasorelaxation of thoracic aortas and in endothelial progenitor cell function, as assessed by the

202 tric oxide (NO) is a key regulator of EC and endothelial progenitor cell function, but the pathophysi

203 athway plays an important role in modulating endothelial progenitor cell function, playing a critical

204 Utilizing Nf1+/- mice, primary human ECs and endothelial progenitor cells harvested from NF1 patients

205 ically engineered mesenchymal stem cells and endothelial progenitor cells has been explored as a rege

206 In this new field, characterization of endothelial progenitor cells has presented new opportuni

207 bone marrow-derived cell populations, called endothelial progenitor cells, have been reported to poss

208 layer consisted of human cord blood-derived endothelial progenitor cells (hCB-EPCs) from a separate,

209 mal cell sheets (hMSC) as the wall and human endothelial progenitor cell (hEPC) coating as the lumen.

210 Human endothelial progenitor cells (hEPCs) participate in neov

211 release of SDF-1, a chemokine that promotes endothelial progenitor cell homing and angiogenesis, fro

212 the differentiation capacity of bone marrow endothelial progenitor cells, improved endothelium-depen

213 Since the identification of the endothelial progenitor cell in 1997 by Asahara and Isner

214 e assessed at multiple time points using rat endothelial progenitor cells in a transwell migration as

215 While evidence of the importance of endothelial progenitor cells in adult vasculogenesis inc

216 The quantity of endothelial progenitor cells in patients with acute lung

217 mor progression have 2-fold more circulating endothelial progenitor cells in peripheral blood than co

218 tometry was performed to measure circulating endothelial progenitor cells in peripheral blood.

219 The miR array data from endothelial progenitor cells in response to inflammatory

220 is expressed in tumor neovasculature and on endothelial progenitor cells in the bone marrow, was lab

221 , exhibited an increased number of lymphatic endothelial progenitor cells in the cardinal veins, toge

222 ining the role of murine bone marrow-derived endothelial progenitor cells in the process of tumor neo

223 This correlated with a 30% increase in endothelial progenitor cells in the retina at postnatal

224 By contrasting the role of endothelial progenitor cells in tissue regeneration with

225 lary density, as well as bone marrow-derived endothelial progenitor cells incorporation into the func

226 situ differentiation of bone marrow-derived endothelial progenitor cells into endothelial cells.

227 In addition, the role of bone marrow-derived endothelial progenitor cells is discussed as are the pot

228 ance by CYP26B1 in the vicinity of lymphatic endothelial progenitor cells is important for determinin

229 Late outgrowth endothelial progenitor cells isolated from HPAH patients

230 g promotes differentiation and maturation of endothelial progenitor cells, its role in the differenti

231 sFlt1 with concomitant decreased circulating endothelial progenitor cell levels along with inappropri

232 Endothelial progenitor cell levels were highest in patie

233 Baseline flow-mediated dilation and endothelial progenitor cell levels were lower in patient

234 Circulating endothelial progenitor cell levels were quantified to as

235 ncy is associated with decreased circulating endothelial progenitor cells-like CD31(+)/c-Kit(+) cells

236 However, in contrast to endothelial progenitor cells, mature LSECs express littl

237 Further evidence suggests that stem cells or endothelial progenitor cells may be released from both b

238 vasa vasorum, as well as bone marrow-derived endothelial progenitor cells may be subject to proathero

239 ecting impaired mobilization and function of endothelial progenitor cells, may precede "macrovascular

240 present study suggests that ischemia-induced endothelial progenitor cell-mediated neovascularization

241 corporeal shock wave and bone marrow-derived endothelial progenitor cells might exert enhanced protec

242 scular endothelial growth factor expression, endothelial progenitor cell mobilization from bone marro

243 ypes, including hematopoietic stem cells and endothelial progenitor cells, more efficiently than the

244 roliferative capacity of ECs and circulating endothelial progenitor cell numbers after vascular injur

245 glitazone in improving endothelial function, endothelial progenitor cell numbers and functional capac

246 d Notch signaling increased Prox1+ lymphatic endothelial progenitor cell numbers in the veins, leadin

247 under oxidative stress, as well as decreased endothelial progenitor cell numbers were responsible for

248 and significantly increased Prox1+ lymphatic endothelial progenitor cell numbers.

249 ylation in cord blood-derived late outgrowth endothelial progenitor cells (OEPCs).

250 ECs expanded from blood-derived endothelial progenitor cells of VWD patients confirmed t

251 ve is superior to either bone marrow-derived endothelial progenitor cells or extracorporeal shock wav

252 eproduced in vitro by incubation of cultured endothelial progenitor cells or spleen-derived endotheli

253 such as peripheral hematopoietic stem cells, endothelial progenitor cells, or circulating tumor cells

254 Delivery of endothelial progenitor cells overexpressing endothelial

255 ematopoietic stem cells and depleted splenic endothelial progenitor cells, partially reproducing the

256 To clarify the origin of endothelial progenitor cells participating in endothelia

257 Participants underwent endothelial progenitor cell phenotyping with an early-ou

258 Putative endothelial progenitor cells play a role in organ regene

259 Multicolor flow cytometry quantified the endothelial progenitor cell population in the bone marro

260 further enriched by selection for a CD133(+) endothelial progenitor cell population.

261 ng living individuals, and its knock-down in endothelial progenitor cells precludes their capacity to

262 It has been demonstrated that endothelial progenitor cells present in the blood have a

263 lesions expressed markers characteristic of endothelial progenitor cells, produced angiogenic factor

264 Furthermore, Shh directly promoted endothelial progenitor cell proliferation, migration, ad

265 Artery Disease Patients: Interaction Between Endothelial Progenitor Cells, Reactivity of Micro- and M

266 The endothelial progenitor cell recently emerged as an impor

267 d pericyte recruitment, but no impairment in endothelial progenitor cell recruitment.

268 e enhancer identified here becomes active in endothelial progenitor cells shortly after their initial

269 pecimen was performed for endothelial cells, endothelial progenitor cells, smooth muscle cells, and i

270 Specifically, endothelial cell/endothelial progenitor cell survival, vascular endotheli

271 ain reaction and generated higher numbers of endothelial progenitor cells than CD31(-) cells did.

272 s study provides strong evidence in neonatal endothelial progenitor cells that GDM exposure in utero

273 abolites by gut endothelium requires MFSD2A; endothelial progenitor cells that overexpress MFSD2A red

274 Human circulating endothelial progenitor cells that overexpress MFSD2A wer

275 In mice with colitis, transplanted endothelial progenitor cells that overexpressed MFSD2A n

276 etic tissue can provide a source of vascular endothelial progenitor cells throughout life.

277 ls of type I IFNs to disrupt the capacity of endothelial progenitor cells to differentiate into matur

278 essed by the capacity of bone marrow-derived endothelial progenitor cells to differentiate into matur

279 en restored the resistance of both BMDCs and endothelial progenitor cells to oxidative stress, improv

280 ineered vessel can be seeded with autologous endothelial progenitor cells to provide a biological vas

281 the migration, recruitment, and retention of endothelial progenitor cells to sites of ischemic injury

282 igration of green fluorescent protein-tagged endothelial progenitor cells to tumor tissues.

283 study of the tolerability of culture-derived endothelial progenitor cells, transiently transfected wi

284 g tissues and organs, but clinical trials of endothelial progenitor cell transplantation have not res

285 Enhanced apoptosis of endothelial progenitor cells under oxidative stress, as

286 including RhoA/Rho kinase, tyrosine kinase, endothelial progenitor cells, vasoactive intestinal pept

287 ized green fluorescent protein-Tie2-positive endothelial progenitor cells versus controls, with a cor

288 homeostasis: the regenerative production of endothelial progenitor cells, vessel wall angiogenesis,

289 The Rejuvenating Endothelial Progenitor Cells via Transcutaneous Intra-ar

290 with CLI (n=33) included in the Rejuvenating Endothelial Progenitor Cells via Transcutaneous Intra-ar

291 flammatory stimuli, the miR array profile of endothelial progenitor cells was analyzed using a polyme

292 he number of circulating bone marrow-derived endothelial progenitor cells was significantly reduced i

293 Endothelial progenitor cells were CD31+, vWF+, and alpha

294 Endothelial progenitor cells were not observed along the

295 The implanted endothelial progenitor cells were restricted to the lumi

296 Characterized ovine peripheral blood endothelial progenitor cells were seeded onto scaffolds

297 e that hematopoietic tissues are a source of endothelial progenitor cells, which contribute to newly

298 ed cellularity and altered the phenotypes of endothelial progenitor cells, which resulted in changes

299 uch a lentiviral vector can be used to endow endothelial progenitor cells with anti-tumor properties.

300 udy was to determine the role of circulating endothelial progenitor cells with osteoblastic phenotype